Orthofix Medical Inc. Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount
Orthofix Medical Inc. (OFIX) reported Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount of $818.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-24.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities · last filed 2020-02-24
- Orthofix Medical Inc. effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2017 was $818.00K.
- Orthofix Medical Inc. effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2015 was $469.00K, a 24.40% increase from fiscal 2014.
- Orthofix Medical Inc. effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2014 was $377.00K, a 61.80% increase from fiscal 2013.
- Orthofix Medical Inc. effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2013 was $233.00K, a 85.13% decline from fiscal 2012.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount 12 month | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount 12 month as first filed |
|---|---|---|
| 2017-12-31 | $818.00K 10-K · filed 2020-02-24 | |
| 2015-12-31 | $469.00K 10-K · filed 2018-02-26 | |
| 2014-12-31 | $377.00K 10-K · filed 2017-02-27 | |
| 2013-12-31 | $233.00K 10-K · filed 2016-02-29 | |
| 2012-12-31 | $1.57M 10-K · filed 2015-04-29 | $1.53M 10-K · filed 2013-03-01 |
| 2011-12-31 | $1.70M 10-K/A · filed 2015-03-31 | $1.42M 10-K · filed 2012-02-29 |
| 2010-12-31 | $1.53M 10-K/A · filed 2014-03-24 | $1.94M 10-K · filed 2012-02-29 |
| 2009-12-31 | $839.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |